For individuals living with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a serious condition, the arrival of this treatment and Attruby represents a genuine advancement . These groundbreaking therapies stabilize the transthyretin protein, preventing its damaging build-up and reducing the impact of the illness. Individuals are now seeing benefits